1 Study Coverage
1.1 Bipolar Disorder Drugs and Treatment Product Introduction
1.2 Market by Type
1.2.1 Global Bipolar Disorder Drugs and Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Mood Stabilizers
1.2.3 Anticonvulsants
1.2.4 Antipsychotic Drugs
1.2.5 Antidepressant Drugs
1.2.6 Anti-Anxiety Drugs
1.3 Market by Application
1.3.1 Global Bipolar Disorder Drugs and Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Bipolar Disorder Drugs and Treatment Sales Estimates and Forecasts 2017-2028
2.2 Global Bipolar Disorder Drugs and Treatment Revenue Estimates and Forecasts 2017-2028
2.3 Global Bipolar Disorder Drugs and Treatment Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Bipolar Disorder Drugs and Treatment Sales by Region
2.4.1 Global Bipolar Disorder Drugs and Treatment Sales by Region (2017-2022)
2.4.2 Global Sales Bipolar Disorder Drugs and Treatment by Region (2023-2028)
2.5 Global Bipolar Disorder Drugs and Treatment Revenue by Region
2.5.1 Global Bipolar Disorder Drugs and Treatment Revenue by Region (2017-2022)
2.5.2 Global Bipolar Disorder Drugs and Treatment Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Bipolar Disorder Drugs and Treatment Sales by Manufacturers
3.1.1 Global Top Bipolar Disorder Drugs and Treatment Manufacturers by Sales (2017-2022)
3.1.2 Global Bipolar Disorder Drugs and Treatment Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Bipolar Disorder Drugs and Treatment in 2021
3.2 Global Bipolar Disorder Drugs and Treatment Revenue by Manufacturers
3.2.1 Global Bipolar Disorder Drugs and Treatment Revenue by Manufacturers (2017-2022)
3.2.2 Global Bipolar Disorder Drugs and Treatment Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Bipolar Disorder Drugs and Treatment Revenue in 2021
3.3 Global Bipolar Disorder Drugs and Treatment Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Bipolar Disorder Drugs and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Bipolar Disorder Drugs and Treatment Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Bipolar Disorder Drugs and Treatment Sales by Type
4.1.1 Global Bipolar Disorder Drugs and Treatment Historical Sales by Type (2017-2022)
4.1.2 Global Bipolar Disorder Drugs and Treatment Forecasted Sales by Type (2023-2028)
4.1.3 Global Bipolar Disorder Drugs and Treatment Sales Market Share by Type (2017-2028)
4.2 Global Bipolar Disorder Drugs and Treatment Revenue by Type
4.2.1 Global Bipolar Disorder Drugs and Treatment Historical Revenue by Type (2017-2022)
4.2.2 Global Bipolar Disorder Drugs and Treatment Forecasted Revenue by Type (2023-2028)
4.2.3 Global Bipolar Disorder Drugs and Treatment Revenue Market Share by Type (2017-2028)
4.3 Global Bipolar Disorder Drugs and Treatment Price by Type
4.3.1 Global Bipolar Disorder Drugs and Treatment Price by Type (2017-2022)
4.3.2 Global Bipolar Disorder Drugs and Treatment Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Bipolar Disorder Drugs and Treatment Sales by Application
5.1.1 Global Bipolar Disorder Drugs and Treatment Historical Sales by Application (2017-2022)
5.1.2 Global Bipolar Disorder Drugs and Treatment Forecasted Sales by Application (2023-2028)
5.1.3 Global Bipolar Disorder Drugs and Treatment Sales Market Share by Application (2017-2028)
5.2 Global Bipolar Disorder Drugs and Treatment Revenue by Application
5.2.1 Global Bipolar Disorder Drugs and Treatment Historical Revenue by Application (2017-2022)
5.2.2 Global Bipolar Disorder Drugs and Treatment Forecasted Revenue by Application (2023-2028)
5.2.3 Global Bipolar Disorder Drugs and Treatment Revenue Market Share by Application (2017-2028)
5.3 Global Bipolar Disorder Drugs and Treatment Price by Application
5.3.1 Global Bipolar Disorder Drugs and Treatment Price by Application (2017-2022)
5.3.2 Global Bipolar Disorder Drugs and Treatment Price Forecast by Application (2023-2028)
6 North America
6.1 North America Bipolar Disorder Drugs and Treatment Market Size by Type
6.1.1 North America Bipolar Disorder Drugs and Treatment Sales by Type (2017-2028)
6.1.2 North America Bipolar Disorder Drugs and Treatment Revenue by Type (2017-2028)
6.2 North America Bipolar Disorder Drugs and Treatment Market Size by Application
6.2.1 North America Bipolar Disorder Drugs and Treatment Sales by Application (2017-2028)
6.2.2 North America Bipolar Disorder Drugs and Treatment Revenue by Application (2017-2028)
6.3 North America Bipolar Disorder Drugs and Treatment Market Size by Country
6.3.1 North America Bipolar Disorder Drugs and Treatment Sales by Country (2017-2028)
6.3.2 North America Bipolar Disorder Drugs and Treatment Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Bipolar Disorder Drugs and Treatment Market Size by Type
7.1.1 Europe Bipolar Disorder Drugs and Treatment Sales by Type (2017-2028)
7.1.2 Europe Bipolar Disorder Drugs and Treatment Revenue by Type (2017-2028)
7.2 Europe Bipolar Disorder Drugs and Treatment Market Size by Application
7.2.1 Europe Bipolar Disorder Drugs and Treatment Sales by Application (2017-2028)
7.2.2 Europe Bipolar Disorder Drugs and Treatment Revenue by Application (2017-2028)
7.3 Europe Bipolar Disorder Drugs and Treatment Market Size by Country
7.3.1 Europe Bipolar Disorder Drugs and Treatment Sales by Country (2017-2028)
7.3.2 Europe Bipolar Disorder Drugs and Treatment Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Bipolar Disorder Drugs and Treatment Market Size by Type
8.1.1 Asia Pacific Bipolar Disorder Drugs and Treatment Sales by Type (2017-2028)
8.1.2 Asia Pacific Bipolar Disorder Drugs and Treatment Revenue by Type (2017-2028)
8.2 Asia Pacific Bipolar Disorder Drugs and Treatment Market Size by Application
8.2.1 Asia Pacific Bipolar Disorder Drugs and Treatment Sales by Application (2017-2028)
8.2.2 Asia Pacific Bipolar Disorder Drugs and Treatment Revenue by Application (2017-2028)
8.3 Asia Pacific Bipolar Disorder Drugs and Treatment Market Size by Region
8.3.1 Asia Pacific Bipolar Disorder Drugs and Treatment Sales by Region (2017-2028)
8.3.2 Asia Pacific Bipolar Disorder Drugs and Treatment Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Bipolar Disorder Drugs and Treatment Market Size by Type
9.1.1 Latin America Bipolar Disorder Drugs and Treatment Sales by Type (2017-2028)
9.1.2 Latin America Bipolar Disorder Drugs and Treatment Revenue by Type (2017-2028)
9.2 Latin America Bipolar Disorder Drugs and Treatment Market Size by Application
9.2.1 Latin America Bipolar Disorder Drugs and Treatment Sales by Application (2017-2028)
9.2.2 Latin America Bipolar Disorder Drugs and Treatment Revenue by Application (2017-2028)
9.3 Latin America Bipolar Disorder Drugs and Treatment Market Size by Country
9.3.1 Latin America Bipolar Disorder Drugs and Treatment Sales by Country (2017-2028)
9.3.2 Latin America Bipolar Disorder Drugs and Treatment Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Bipolar Disorder Drugs and Treatment Market Size by Type
10.1.1 Middle East and Africa Bipolar Disorder Drugs and Treatment Sales by Type (2017-2028)
10.1.2 Middle East and Africa Bipolar Disorder Drugs and Treatment Revenue by Type (2017-2028)
10.2 Middle East and Africa Bipolar Disorder Drugs and Treatment Market Size by Application
10.2.1 Middle East and Africa Bipolar Disorder Drugs and Treatment Sales by Application (2017-2028)
10.2.2 Middle East and Africa Bipolar Disorder Drugs and Treatment Revenue by Application (2017-2028)
10.3 Middle East and Africa Bipolar Disorder Drugs and Treatment Market Size by Country
10.3.1 Middle East and Africa Bipolar Disorder Drugs and Treatment Sales by Country (2017-2028)
10.3.2 Middle East and Africa Bipolar Disorder Drugs and Treatment Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AbbVie Inc.
11.1.1 AbbVie Inc. Corporation Information
11.1.2 AbbVie Inc. Overview
11.1.3 AbbVie Inc. Bipolar Disorder Drugs and Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AbbVie Inc. Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AbbVie Inc. Recent Developments
11.2 Glaxo SmithKline (GSK)
11.2.1 Glaxo SmithKline (GSK) Corporation Information
11.2.2 Glaxo SmithKline (GSK) Overview
11.2.3 Glaxo SmithKline (GSK) Bipolar Disorder Drugs and Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Glaxo SmithKline (GSK) Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Glaxo SmithKline (GSK) Recent Developments
11.3 Eli Lily and Company
11.3.1 Eli Lily and Company Corporation Information
11.3.2 Eli Lily and Company Overview
11.3.3 Eli Lily and Company Bipolar Disorder Drugs and Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Eli Lily and Company Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eli Lily and Company Recent Developments
11.4 Janssen Pharmaceuticals
11.4.1 Janssen Pharmaceuticals Corporation Information
11.4.2 Janssen Pharmaceuticals Overview
11.4.3 Janssen Pharmaceuticals Bipolar Disorder Drugs and Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Janssen Pharmaceuticals Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Janssen Pharmaceuticals Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Corporation Information
11.5.2 Johnson & Johnson Overview
11.5.3 Johnson & Johnson Bipolar Disorder Drugs and Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Johnson & Johnson Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Johnson & Johnson Recent Developments
11.6 Astellas Pharma Inc
11.6.1 Astellas Pharma Inc Corporation Information
11.6.2 Astellas Pharma Inc Overview
11.6.3 Astellas Pharma Inc Bipolar Disorder Drugs and Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Astellas Pharma Inc Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Astellas Pharma Inc Recent Developments
11.7 Bristol Myers Squibb
11.7.1 Bristol Myers Squibb Corporation Information
11.7.2 Bristol Myers Squibb Overview
11.7.3 Bristol Myers Squibb Bipolar Disorder Drugs and Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Bristol Myers Squibb Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bristol Myers Squibb Recent Developments
11.8 Gedeon Richter PLC.
11.8.1 Gedeon Richter PLC. Corporation Information
11.8.2 Gedeon Richter PLC. Overview
11.8.3 Gedeon Richter PLC. Bipolar Disorder Drugs and Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Gedeon Richter PLC. Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Gedeon Richter PLC. Recent Developments
11.9 H. Lundbeck A/S
11.9.1 H. Lundbeck A/S Corporation Information
11.9.2 H. Lundbeck A/S Overview
11.9.3 H. Lundbeck A/S Bipolar Disorder Drugs and Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 H. Lundbeck A/S Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 H. Lundbeck A/S Recent Developments
11.10 Pfizer Inc.
11.10.1 Pfizer Inc. Corporation Information
11.10.2 Pfizer Inc. Overview
11.10.3 Pfizer Inc. Bipolar Disorder Drugs and Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Pfizer Inc. Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Pfizer Inc. Recent Developments
11.11 Novartis AG
11.11.1 Novartis AG Corporation Information
11.11.2 Novartis AG Overview
11.11.3 Novartis AG Bipolar Disorder Drugs and Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Novartis AG Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Novartis AG Recent Developments
11.12 Otsuka Holdings Co. Ltd
11.12.1 Otsuka Holdings Co. Ltd Corporation Information
11.12.2 Otsuka Holdings Co. Ltd Overview
11.12.3 Otsuka Holdings Co. Ltd Bipolar Disorder Drugs and Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Otsuka Holdings Co. Ltd Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Otsuka Holdings Co. Ltd Recent Developments
11.13 Validus Pharmaceuticals LLC.
11.13.1 Validus Pharmaceuticals LLC. Corporation Information
11.13.2 Validus Pharmaceuticals LLC. Overview
11.13.3 Validus Pharmaceuticals LLC. Bipolar Disorder Drugs and Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Validus Pharmaceuticals LLC. Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Validus Pharmaceuticals LLC. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Bipolar Disorder Drugs and Treatment Industry Chain Analysis
12.2 Bipolar Disorder Drugs and Treatment Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Bipolar Disorder Drugs and Treatment Production Mode & Process
12.4 Bipolar Disorder Drugs and Treatment Sales and Marketing
12.4.1 Bipolar Disorder Drugs and Treatment Sales Channels
12.4.2 Bipolar Disorder Drugs and Treatment Distributors
12.5 Bipolar Disorder Drugs and Treatment Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Bipolar Disorder Drugs and Treatment Industry Trends
13.2 Bipolar Disorder Drugs and Treatment Market Drivers
13.3 Bipolar Disorder Drugs and Treatment Market Challenges
13.4 Bipolar Disorder Drugs and Treatment Market Restraints
14 Key Findings in The Global Bipolar Disorder Drugs and Treatment Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Bipolar Disorder Drugs and Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Mood Stabilizers
Table 3. Major Manufacturers of Anticonvulsants
Table 4. Major Manufacturers of Antipsychotic Drugs
Table 5. Major Manufacturers of Antidepressant Drugs
Table 6. Major Manufacturers of Anti-Anxiety Drugs
Table 7. Global Bipolar Disorder Drugs and Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Bipolar Disorder Drugs and Treatment Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Bipolar Disorder Drugs and Treatment Sales by Region (2017-2022) & (K Units)
Table 10. Global Bipolar Disorder Drugs and Treatment Sales Market Share by Region (2017-2022)
Table 11. Global Bipolar Disorder Drugs and Treatment Sales by Region (2023-2028) & (K Units)
Table 12. Global Bipolar Disorder Drugs and Treatment Sales Market Share by Region (2023-2028)
Table 13. Global Bipolar Disorder Drugs and Treatment Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Bipolar Disorder Drugs and Treatment Revenue Market Share by Region (2017-2022)
Table 15. Global Bipolar Disorder Drugs and Treatment Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Bipolar Disorder Drugs and Treatment Revenue Market Share by Region (2023-2028)
Table 17. Global Bipolar Disorder Drugs and Treatment Sales by Manufacturers (2017-2022) & (K Units)
Table 18. Global Bipolar Disorder Drugs and Treatment Sales Share by Manufacturers (2017-2022)
Table 19. Global Bipolar Disorder Drugs and Treatment Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Bipolar Disorder Drugs and Treatment Revenue Share by Manufacturers (2017-2022)
Table 21. Bipolar Disorder Drugs and Treatment Price by Manufacturers (2017-2022) &(US$/Unit)
Table 22. Global Bipolar Disorder Drugs and Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Bipolar Disorder Drugs and Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bipolar Disorder Drugs and Treatment as of 2021)
Table 24. Bipolar Disorder Drugs and Treatment Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Bipolar Disorder Drugs and Treatment Product Offered
Table 26. Date of Manufacturers Enter into Bipolar Disorder Drugs and Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Bipolar Disorder Drugs and Treatment Sales by Type (2017-2022) & (K Units)
Table 29. Global Bipolar Disorder Drugs and Treatment Sales by Type (2023-2028) & (K Units)
Table 30. Global Bipolar Disorder Drugs and Treatment Sales Share by Type (2017-2022)
Table 31. Global Bipolar Disorder Drugs and Treatment Sales Share by Type (2023-2028)
Table 32. Global Bipolar Disorder Drugs and Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Bipolar Disorder Drugs and Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Bipolar Disorder Drugs and Treatment Revenue Share by Type (2017-2022)
Table 35. Global Bipolar Disorder Drugs and Treatment Revenue Share by Type (2023-2028)
Table 36. Bipolar Disorder Drugs and Treatment Price by Type (2017-2022) & (US$/Unit)
Table 37. Global Bipolar Disorder Drugs and Treatment Price Forecast by Type (2023-2028) & (US$/Unit)
Table 38. Global Bipolar Disorder Drugs and Treatment Sales by Application (2017-2022) & (K Units)
Table 39. Global Bipolar Disorder Drugs and Treatment Sales by Application (2023-2028) & (K Units)
Table 40. Global Bipolar Disorder Drugs and Treatment Sales Share by Application (2017-2022)
Table 41. Global Bipolar Disorder Drugs and Treatment Sales Share by Application (2023-2028)
Table 42. Global Bipolar Disorder Drugs and Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Bipolar Disorder Drugs and Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Bipolar Disorder Drugs and Treatment Revenue Share by Application (2017-2022)
Table 45. Global Bipolar Disorder Drugs and Treatment Revenue Share by Application (2023-2028)
Table 46. Bipolar Disorder Drugs and Treatment Price by Application (2017-2022) & (US$/Unit)
Table 47. Global Bipolar Disorder Drugs and Treatment Price Forecast by Application (2023-2028) & (US$/Unit)
Table 48. North America Bipolar Disorder Drugs and Treatment Sales by Type (2017-2022) & (K Units)
Table 49. North America Bipolar Disorder Drugs and Treatment Sales by Type (2023-2028) & (K Units)
Table 50. North America Bipolar Disorder Drugs and Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Bipolar Disorder Drugs and Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Bipolar Disorder Drugs and Treatment Sales by Application (2017-2022) & (K Units)
Table 53. North America Bipolar Disorder Drugs and Treatment Sales by Application (2023-2028) & (K Units)
Table 54. North America Bipolar Disorder Drugs and Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Bipolar Disorder Drugs and Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Bipolar Disorder Drugs and Treatment Sales by Country (2017-2022) & (K Units)
Table 57. North America Bipolar Disorder Drugs and Treatment Sales by Country (2023-2028) & (K Units)
Table 58. North America Bipolar Disorder Drugs and Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Bipolar Disorder Drugs and Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Bipolar Disorder Drugs and Treatment Sales by Type (2017-2022) & (K Units)
Table 61. Europe Bipolar Disorder Drugs and Treatment Sales by Type (2023-2028) & (K Units)
Table 62. Europe Bipolar Disorder Drugs and Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Bipolar Disorder Drugs and Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Bipolar Disorder Drugs and Treatment Sales by Application (2017-2022) & (K Units)
Table 65. Europe Bipolar Disorder Drugs and Treatment Sales by Application (2023-2028) & (K Units)
Table 66. Europe Bipolar Disorder Drugs and Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Bipolar Disorder Drugs and Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Bipolar Disorder Drugs and Treatment Sales by Country (2017-2022) & (K Units)
Table 69. Europe Bipolar Disorder Drugs and Treatment Sales by Country (2023-2028) & (K Units)
Table 70. Europe Bipolar Disorder Drugs and Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Bipolar Disorder Drugs and Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Bipolar Disorder Drugs and Treatment Sales by Type (2017-2022) & (K Units)
Table 73. Asia Pacific Bipolar Disorder Drugs and Treatment Sales by Type (2023-2028) & (K Units)
Table 74. Asia Pacific Bipolar Disorder Drugs and Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Bipolar Disorder Drugs and Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Bipolar Disorder Drugs and Treatment Sales by Application (2017-2022) & (K Units)
Table 77. Asia Pacific Bipolar Disorder Drugs and Treatment Sales by Application (2023-2028) & (K Units)
Table 78. Asia Pacific Bipolar Disorder Drugs and Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Bipolar Disorder Drugs and Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Bipolar Disorder Drugs and Treatment Sales by Region (2017-2022) & (K Units)
Table 81. Asia Pacific Bipolar Disorder Drugs and Treatment Sales by Region (2023-2028) & (K Units)
Table 82. Asia Pacific Bipolar Disorder Drugs and Treatment Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Bipolar Disorder Drugs and Treatment Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Bipolar Disorder Drugs and Treatment Sales by Type (2017-2022) & (K Units)
Table 85. Latin America Bipolar Disorder Drugs and Treatment Sales by Type (2023-2028) & (K Units)
Table 86. Latin America Bipolar Disorder Drugs and Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Bipolar Disorder Drugs and Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Bipolar Disorder Drugs and Treatment Sales by Application (2017-2022) & (K Units)
Table 89. Latin America Bipolar Disorder Drugs and Treatment Sales by Application (2023-2028) & (K Units)
Table 90. Latin America Bipolar Disorder Drugs and Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Bipolar Disorder Drugs and Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Bipolar Disorder Drugs and Treatment Sales by Country (2017-2022) & (K Units)
Table 93. Latin America Bipolar Disorder Drugs and Treatment Sales by Country (2023-2028) & (K Units)
Table 94. Latin America Bipolar Disorder Drugs and Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Bipolar Disorder Drugs and Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Bipolar Disorder Drugs and Treatment Sales by Type (2017-2022) & (K Units)
Table 97. Middle East and Africa Bipolar Disorder Drugs and Treatment Sales by Type (2023-2028) & (K Units)
Table 98. Middle East and Africa Bipolar Disorder Drugs and Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Bipolar Disorder Drugs and Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Bipolar Disorder Drugs and Treatment Sales by Application (2017-2022) & (K Units)
Table 101. Middle East and Africa Bipolar Disorder Drugs and Treatment Sales by Application (2023-2028) & (K Units)
Table 102. Middle East and Africa Bipolar Disorder Drugs and Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Bipolar Disorder Drugs and Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Bipolar Disorder Drugs and Treatment Sales by Country (2017-2022) & (K Units)
Table 105. Middle East and Africa Bipolar Disorder Drugs and Treatment Sales by Country (2023-2028) & (K Units)
Table 106. Middle East and Africa Bipolar Disorder Drugs and Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Bipolar Disorder Drugs and Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 108. AbbVie Inc. Corporation Information
Table 109. AbbVie Inc. Description and Major Businesses
Table 110. AbbVie Inc. Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 111. AbbVie Inc. Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. AbbVie Inc. Recent Developments
Table 113. Glaxo SmithKline (GSK) Corporation Information
Table 114. Glaxo SmithKline (GSK) Description and Major Businesses
Table 115. Glaxo SmithKline (GSK) Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 116. Glaxo SmithKline (GSK) Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Glaxo SmithKline (GSK) Recent Developments
Table 118. Eli Lily and Company Corporation Information
Table 119. Eli Lily and Company Description and Major Businesses
Table 120. Eli Lily and Company Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 121. Eli Lily and Company Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Eli Lily and Company Recent Developments
Table 123. Janssen Pharmaceuticals Corporation Information
Table 124. Janssen Pharmaceuticals Description and Major Businesses
Table 125. Janssen Pharmaceuticals Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 126. Janssen Pharmaceuticals Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Janssen Pharmaceuticals Recent Developments
Table 128. Johnson & Johnson Corporation Information
Table 129. Johnson & Johnson Description and Major Businesses
Table 130. Johnson & Johnson Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 131. Johnson & Johnson Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Johnson & Johnson Recent Developments
Table 133. Astellas Pharma Inc Corporation Information
Table 134. Astellas Pharma Inc Description and Major Businesses
Table 135. Astellas Pharma Inc Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 136. Astellas Pharma Inc Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Astellas Pharma Inc Recent Developments
Table 138. Bristol Myers Squibb Corporation Information
Table 139. Bristol Myers Squibb Description and Major Businesses
Table 140. Bristol Myers Squibb Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 141. Bristol Myers Squibb Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Bristol Myers Squibb Recent Developments
Table 143. Gedeon Richter PLC. Corporation Information
Table 144. Gedeon Richter PLC. Description and Major Businesses
Table 145. Gedeon Richter PLC. Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 146. Gedeon Richter PLC. Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Gedeon Richter PLC. Recent Developments
Table 148. H. Lundbeck A/S Corporation Information
Table 149. H. Lundbeck A/S Description and Major Businesses
Table 150. H. Lundbeck A/S Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 151. H. Lundbeck A/S Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. H. Lundbeck A/S Recent Developments
Table 153. Pfizer Inc. Corporation Information
Table 154. Pfizer Inc. Description and Major Businesses
Table 155. Pfizer Inc. Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 156. Pfizer Inc. Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Pfizer Inc. Recent Developments
Table 158. Novartis AG Corporation Information
Table 159. Novartis AG Description and Major Businesses
Table 160. Novartis AG Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 161. Novartis AG Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Novartis AG Recent Developments
Table 163. Otsuka Holdings Co. Ltd Corporation Information
Table 164. Otsuka Holdings Co. Ltd Description and Major Businesses
Table 165. Otsuka Holdings Co. Ltd Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 166. Otsuka Holdings Co. Ltd Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Otsuka Holdings Co. Ltd Recent Developments
Table 168. Validus Pharmaceuticals LLC. Corporation Information
Table 169. Validus Pharmaceuticals LLC. Description and Major Businesses
Table 170. Validus Pharmaceuticals LLC. Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 171. Validus Pharmaceuticals LLC. Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Validus Pharmaceuticals LLC. Recent Developments
Table 173. Key Raw Materials Lists
Table 174. Raw Materials Key Suppliers Lists
Table 175. Bipolar Disorder Drugs and Treatment Distributors List
Table 176. Bipolar Disorder Drugs and Treatment Customers List
Table 177. Bipolar Disorder Drugs and Treatment Market Trends
Table 178. Bipolar Disorder Drugs and Treatment Market Drivers
Table 179. Bipolar Disorder Drugs and Treatment Market Challenges
Table 180. Bipolar Disorder Drugs and Treatment Market Restraints
Table 181. Research Programs/Design for This Report
Table 182. Key Data Information from Secondary Sources
Table 183. Key Data Information from Primary Sources
List of Figures
Figure 1. Bipolar Disorder Drugs and Treatment Product Picture
Figure 3. Global Bipolar Disorder Drugs and Treatment Market Share by Type in 2021 & 2028
Figure 3. Mood Stabilizers Product Picture
Figure 4. Anticonvulsants Product Picture
Figure 5. Antipsychotic Drugs Product Picture
Figure 6. Antidepressant Drugs Product Picture
Figure 7. Anti-Anxiety Drugs Product Picture
Figure 8. Global Bipolar Disorder Drugs and Treatment Market Share by Application in 2021 & 2028
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Bipolar Disorder Drugs and Treatment Report Years Considered
Figure 12. Global Bipolar Disorder Drugs and Treatment Sales 2017-2028 (K Units)
Figure 13. Global Bipolar Disorder Drugs and Treatment Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Bipolar Disorder Drugs and Treatment Revenue 2017-2028 (US$ Million)
Figure 15. Global Bipolar Disorder Drugs and Treatment Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Bipolar Disorder Drugs and Treatment Sales Market Share by Region (2017-2022)
Figure 17. Global Bipolar Disorder Drugs and Treatment Sales Market Share by Region (2023-2028)
Figure 18. North America Bipolar Disorder Drugs and Treatment Sales YoY (2017-2028) & (K Units)
Figure 19. North America Bipolar Disorder Drugs and Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Bipolar Disorder Drugs and Treatment Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Bipolar Disorder Drugs and Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Bipolar Disorder Drugs and Treatment Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Bipolar Disorder Drugs and Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Bipolar Disorder Drugs and Treatment Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Bipolar Disorder Drugs and Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Bipolar Disorder Drugs and Treatment Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Bipolar Disorder Drugs and Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Bipolar Disorder Drugs and Treatment Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Bipolar Disorder Drugs and Treatment in the World: Market Share by Bipolar Disorder Drugs and Treatment Revenue in 2021
Figure 30. Global Bipolar Disorder Drugs and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Bipolar Disorder Drugs and Treatment Sales Market Share by Type (2017-2028)
Figure 32. Global Bipolar Disorder Drugs and Treatment Revenue Market Share by Type (2017-2028)
Figure 33. Global Bipolar Disorder Drugs and Treatment Sales Market Share by Application (2017-2028)
Figure 34. Global Bipolar Disorder Drugs and Treatment Revenue Market Share by Application (2017-2028)
Figure 35. North America Bipolar Disorder Drugs and Treatment Sales Market Share by Type (2017-2028)
Figure 36. North America Bipolar Disorder Drugs and Treatment Revenue Market Share by Type (2017-2028)
Figure 37. North America Bipolar Disorder Drugs and Treatment Sales Market Share by Application (2017-2028)
Figure 38. North America Bipolar Disorder Drugs and Treatment Revenue Market Share by Application (2017-2028)
Figure 39. North America Bipolar Disorder Drugs and Treatment Sales Share by Country (2017-2028)
Figure 40. North America Bipolar Disorder Drugs and Treatment Revenue Share by Country (2017-2028)
Figure 41. United States Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Bipolar Disorder Drugs and Treatment Sales Market Share by Type (2017-2028)
Figure 44. Europe Bipolar Disorder Drugs and Treatment Revenue Market Share by Type (2017-2028)
Figure 45. Europe Bipolar Disorder Drugs and Treatment Sales Market Share by Application (2017-2028)
Figure 46. Europe Bipolar Disorder Drugs and Treatment Revenue Market Share by Application (2017-2028)
Figure 47. Europe Bipolar Disorder Drugs and Treatment Sales Share by Country (2017-2028)
Figure 48. Europe Bipolar Disorder Drugs and Treatment Revenue Share by Country (2017-2028)
Figure 49. Germany Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 50. France Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Bipolar Disorder Drugs and Treatment Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Bipolar Disorder Drugs and Treatment Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Bipolar Disorder Drugs and Treatment Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Bipolar Disorder Drugs and Treatment Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Bipolar Disorder Drugs and Treatment Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Bipolar Disorder Drugs and Treatment Revenue Share by Region (2017-2028)
Figure 60. China Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 63. India Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 65. China Taiwan Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Bipolar Disorder Drugs and Treatment Sales Market Share by Type (2017-2028)
Figure 70. Latin America Bipolar Disorder Drugs and Treatment Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Bipolar Disorder Drugs and Treatment Sales Market Share by Application (2017-2028)
Figure 72. Latin America Bipolar Disorder Drugs and Treatment Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Bipolar Disorder Drugs and Treatment Sales Share by Country (2017-2028)
Figure 74. Latin America Bipolar Disorder Drugs and Treatment Revenue Share by Country (2017-2028)
Figure 75. Mexico Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Bipolar Disorder Drugs and Treatment Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Bipolar Disorder Drugs and Treatment Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Bipolar Disorder Drugs and Treatment Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Bipolar Disorder Drugs and Treatment Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Bipolar Disorder Drugs and Treatment Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Bipolar Disorder Drugs and Treatment Revenue Share by Country (2017-2028)
Figure 84. Turkey Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 87. Bipolar Disorder Drugs and Treatment Value Chain
Figure 88. Bipolar Disorder Drugs and Treatment Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
